Voyager Therapeutics, Inc. (VYGR)
2.225
-0.04
(-1.98%)
USD |
NASDAQ |
Oct 13, 10:19
Voyager Therapeutics Market Cap : 136.33M for Oct. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 12, 2026 | 139.09M |
| October 09, 2026 | 150.12M |
| October 08, 2026 | 145.22M |
| October 07, 2026 | 151.35M |
| October 06, 2026 | 150.73M |
| October 05, 2026 | 150.73M |
| October 02, 2026 | 150.12M |
| October 01, 2026 | 163.91M |
| September 30, 2026 | 164.21M |
| September 29, 2026 | 161.76M |
| September 28, 2026 | 165.44M |
| September 25, 2026 | 164.21M |
| September 24, 2026 | 171.57M |
| September 23, 2026 | 175.85M |
| September 22, 2026 | 192.40M |
| September 21, 2026 | 188.72M |
| September 18, 2026 | 189.33M |
| September 17, 2026 | 186.27M |
| September 16, 2026 | 186.88M |
| September 15, 2026 | 189.33M |
| September 14, 2026 | 195.46M |
| September 11, 2026 | 195.46M |
| September 10, 2026 | 195.46M |
| September 09, 2026 | 199.14M |
| September 08, 2026 | 208.33M |
| Date | Value |
|---|---|
| September 04, 2026 | 215.07M |
| September 03, 2026 | 207.10M |
| September 02, 2026 | 216.91M |
| September 01, 2026 | 210.17M |
| August 31, 2026 | 211.39M |
| August 28, 2026 | 216.91M |
| August 27, 2026 | 212.01M |
| August 26, 2026 | 212.01M |
| August 25, 2026 | 213.23M |
| August 24, 2026 | 210.78M |
| August 21, 2026 | 207.72M |
| August 20, 2026 | 203.43M |
| August 19, 2026 | 208.94M |
| August 18, 2026 | 202.20M |
| August 17, 2026 | 197.91M |
| August 14, 2026 | 200.36M |
| August 13, 2026 | 197.30M |
| August 12, 2026 | 196.07M |
| August 11, 2026 | 196.07M |
| August 10, 2026 | 194.24M |
| August 07, 2026 | 200.36M |
| August 06, 2026 | 191.79M |
| August 05, 2026 | 189.95M |
| August 04, 2026 | 191.48M |
| August 03, 2026 | 180.93M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 306.41M |
| Amgen, Inc. | 225.51B |
| Anika Therapeutics, Inc. | 272.34M |
| BioCryst Pharmaceuticals, Inc. | 2.096B |
| Imunon, Inc. | 4.899M |
Market Cap Related Metrics
| PS Ratio | 3.838 |
| Price to Book Value | 0.8831 |
| Price | 2.225 |
| Earnings Yield | -81.50% |